Timing matters: new study looks at speed of blood thinner in severe lung clots
NCT ID NCT06912009
First seen Jan 04, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This study looks at how fast patients in the intensive care unit with a serious lung clot (pulmonary embolism) receive effective blood-thinning medication. Researchers will review data from 100 adults treated between 2014 and 2023 to see how quickly their blood reached a therapeutic level and whether that timing affects survival, clot recurrence, or bleeding. The goal is to improve treatment practices for these critically ill patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service de Réanimation Médicale - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.